DeathREGIDAQNCT03272035
General Practitioners' Felt With Their Patients' Death (REGIDAQ)
An observational study of Death, run by University Hospital, Limoges at 1 site in France.
Trial summary
Very few studies are dealing with the way general practitioners feel the death of their patients. Main studies about that subject are qualitative. It needs quantitative studies to analyse how is felt general practitioners' patients' death. This is an epidemiologic quantitative cross-sectional study. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Death
- How many people
- 481 participants
- Where
- 1 siteFrance
- Study dates
- 13 Feb 2018to 13 May 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: General practitioners from the Nouvelle Aquitaine region
Who may be able to join
- General practitioners from the Nouvelle-Aquitaine region.
- Exclusive or joint exercise of general medicine.
- None retired
Who cannot join
- Retired patricians
- Students, Residents
- General practitioners from another region
- General practitioners with no general medicine activity
Trial locations and contacts
1 site in 1 country.
About this study
Very few studies are dealing with the way general practitioners feel the death of their patients. Main studies about that subject are qualitative. It needs quantitative studies to analyse how is felt general practitioners' patients' death. This is an epidemiologic quantitative cross-sectional study. The Studied population is the whole of the general practitioners of the region Nouvelle-Aquitaine. The primary endpoint is the percentage of the general practitioners which have hard time living with their patients' death. The secondary endpoints are to evaluate the general practitioners' help needing after their patients' death, to evaluate the personal and professional impact of the patient's death, the percentage of general practitioners using chemical aid after their patients' death and to determinate the existence of support facilities to help general practitioners to stand patients' death. The results of that study could help general practitioners to improve their medical practice in the patient's death situation.
- Conditions
- Death
- Keywords
- General practice, death, bereavement
- Medical subject headings
- Death
What is being measured
The primary outcome is the main question the study is designed to answer.
percentage of hard time living
percentage of general practitioners which have hard time living with their patients' death
Measured: 2 months (End of study)
Secondary outcomes (5)
percentage of help needing
percentage of general practitioners which need help after their patients' death
Measured: 2 months (End of study)
percentage of personal impact
percentage of general practitioners which have a personal impact when their patient's death
Measured: 2 months (End of study)
percentage of professional impact
percentage of general practitioners witch have a professional impact when the patient's death
Measured: 2 months (End of study)
percentage of chemical aid using
percentage of general practitioners using chemical aid after their patients' death
Measured: 2 months (End of study)
support facilities
Determinate the existence of support facilities to help general practitioners to stand patients' death
Measured: 2 months (End of study)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Sep 2017
- Study start13 Feb 2018
- Primary completion13 May 2018
- Study completion13 May 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DeathStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 481 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Limoges
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Karen Rudelle, doctor, Principal investigator, University Hospital, Limoges
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03272035
- Sponsor's protocol ID
- I16018 (REGIDAQ)
- Acronym
- REGIDAQ
- Status last verified
- Aug 2017
- First submitted
- 23 Aug 2017
- Last updated
- 23 Jan 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jan 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- General Practitioners' Felt With Their Patients' Death (REGIDAQ)
- ClinicalTrials.gov ID
- NCT03272035
- Acronym / sponsor ID
- REGIDAQ / I16018 (REGIDAQ)
- Conditions
- Death
- Keywords
- General practice, death, bereavement
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 481 participants (actual)
- Lead sponsor
- University Hospital, LimogesUniversity, hospital or other
- Study start
- 13 Feb 2018 (actual)
- Primary completion
- 13 May 2018 (actual)
- Study completion
- 13 May 2018 (actual)
- First posted
- 5 Sep 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Very few studies are dealing with the way general practitioners feel the death of their patients. Main studies about that subject are qualitative. It needs quantitative studies to analyse how is felt general practitioners' patients' death. This is an epidemiologic quantitative cross-sectional study. The Studied population is the whole of the general practitioners of the region Nouvelle-Aquitaine. The primary endpoint is the percentage of the general practitioners which have hard time living with their patients' death. The secondary endpoints are to evaluate the general practitioners' help needing after their patients' death, to evaluate the personal and professional impact of the patient's death, the percentage of general practitioners using chemical aid after their patients' death and to determinate the existence of support facilities to help general practitioners to stand patients' death. The results of that study could help general practitioners to improve their medical practice in the patient's death situation.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- General practitioners from the Nouvelle Aquitaine region
Key inclusion criteria (3 listed)
- General practitioners from the Nouvelle-Aquitaine region.
- Exclusive or joint exercise of general medicine.
- None retired
Key exclusion criteria (4 listed)
- Retired patricians
- Students, Residents
- General practitioners from another region
- General practitioners with no general medicine activity
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
percentage of hard time living
Time frame: 2 months (End of study)
percentage of general practitioners which have hard time living with their patients' death
5 secondary outcomes
percentage of help needing
Time frame: 2 months (End of study)
percentage of personal impact
Time frame: 2 months (End of study)
percentage of professional impact
Time frame: 2 months (End of study)
percentage of chemical aid using
Time frame: 2 months (End of study)
support facilities
Time frame: 2 months (End of study)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jan 2019.
Related trials for Death
Not yet recruiting
Improving Deceased Organ Donation and Transplantation Using the Donation Advisor Clinical Decision Support Tool
Organ Donation After Circulatory Death, Organ Donation
Not yet recruiting
Curriculum Design and Effectiveness in Death and Spiritual Care
Death, Spiritual Care
Not yet recruiting
Miniature In-line Respirator
Brain Death, Respiration, Artificial
RecruitingPhase 1/2
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
RecruitingObservational study
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Chronic Lymphocytic Leukemia (CLL), Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Karen Rudelle, doctor principal investigator
University Hospital, Limoges
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Death, run by University Hospital, Limoges at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
percentage of hard time living (time frame: 2 months (End of study)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2019.